[HTML][HTML] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study …
F Vernieri, C Altamura, N Brunelli, CM Costa… - The journal of headache …, 2021 - Springer
Background The clinical benefit of galcanezumab, demonstrated in randomized clinical trials
(RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness …
(RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness …
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
F Vernieri, C Altamura, N Brunelli, CM Costa… - The Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
The clinical benefit of galcanezumab, demonstrated in randomized clinical trials (RCTs) …
The clinical benefit of galcanezumab, demonstrated in randomized clinical trials (RCTs) …
[PDF][PDF] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
F Vernieri, C Altamura, N Brunelli, CM Costa, C Aurilia… - 2021 - scholar.archive.org
Background: The clinical benefit of galcanezumab, demonstrated in randomized clinical
trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the …
trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the …
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
F Vernieri, C Altamura, N Brunelli, CM Costa… - THE JOURNAL OF …, 2021 - cris.unibo.it
The clinical benefit of galcanezumab, demonstrated in randomized clinical trials (RCTs),
remains to be quantified in real life. This study aimed at evaluating the effectiveness, safety …
remains to be quantified in real life. This study aimed at evaluating the effectiveness, safety …
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
F Vernieri, C Altamura, N Brunelli… - THE JOURNAL OF …, 2021 - iris.unicampus.it
Background: The clinical benefit of galcanezumab, demonstrated in randomized clinical
trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the …
trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the …
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
F Vernieri, C Altamura, N Brunelli… - The Journal of …, 2021 - europepmc.org
Background The clinical benefit of galcanezumab, demonstrated in randomized clinical trials
(RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness …
(RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness …
[PDF][PDF] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
F Vernieri, C Altamura, N Brunelli, CM Costa, C Aurilia… - 2021 - academia.edu
Background: The clinical benefit of galcanezumab, demonstrated in randomized clinical
trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the …
trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the …
[HTML][HTML] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study …
F Vernieri, C Altamura… - The Journal of …, 2021 - thejournalofheadacheandpain …
The clinical benefit of galcanezumab, demonstrated in randomized clinical trials (RCTs),
remains to be quantified in real life. This study aimed at evaluating the effectiveness, safety …
remains to be quantified in real life. This study aimed at evaluating the effectiveness, safety …
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
F Vernieri, C Altamura, N Brunelli… - The journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The clinical benefit of galcanezumab, demonstrated in randomized clinical trials
(RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness …
(RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness …
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
F Vernieri, C Altamura, N Brunelli… - … of Headache & …, 2021 - search.ebscohost.com
Background: The clinical benefit of galcanezumab, demonstrated in randomized clinical
trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the …
trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the …